Kontakt 2006, 8(2):404-411 | DOI: 10.32725/kont.2006.066

Vaccination against influenzaPopularizace vědy

Markéta Kastnerová^1,2,*, Kvetoslava Kotrbová^1,2,3

¹ Jihočeská univerzita v Českých Budějovicích, Zdravotně sociální fakulta, katedra veřejného a sociálního zdravotnictví

² Krajská hygienická stanice Jihočeského kraje se sídlem v Českých Budějovicích

³ Kontaktní a doléčovací centrum pro drogovou závislost, o. s., Háječek, České Budějovice

Influenza is a disease resulting in high morbidity and economical losses in all the labour spheres in the Czech Republic. In expert circles, it is a matter of general opinion that the vaccination with inactivated commercially available vaccines still before the influenza period is one of the most important anti-epidemic provisions against this infection. The vaccination in risk groups can considerably reduce the negative impact of possible influenza epidemic or pandemic not only on this group, but on the population as whole. Cases of death actually occur not only due to influenza but mainly due to its complications, the most important of them being secondary bacterial pneumonia or decompensation of pre-existing disease (cardiac, pulmonary, etc.). Most fatal cases due to influenza occur in elderly people, but all the age groups of the population are involved by this disease in the course of the influenza epidemics. The vaccination against influenza in the Czech Republic is focused on persons who belong to risk groups as specified in Regulation of Ministry of Health No. 439/2000 "On vaccination against infectious diseases". For the persons specified, the vaccination is free of charge. From July 1, Regulation of the Ministry of Health of the Czech Republic No. 225/2005 came in effect, according to which health insurance companies will cover vaccination against influenza for the following groups of persons: Inpatients over 65 years of age, inpatients after the splenectomy and transplantation of haemopoietic cells, inpatients who suffer from severe chronic and pharmacologically treated disease of the heart and blood vessels, airways or kidneys and inpatients with diabetes, as far as they are not vaccinated against influenza within the scope of regular or special vaccination in accordance with Regulation of the Ministry of Health No. 439/2000 Sb. "On vaccination against infectious diseases" in wording of latter regulations.

Keywords: vaccination; prevention; vaccination substance; risk group

Published: December 15, 2006  Show citation